'In vitro' activity of different antimicrobial agents on gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp.;Actividad "in vitro" de diferentes antibacterianos sobre bacilos gram-negativos no fermentadores, excluidos Pseudomonas aeruginosa y Acinetobacter spp.

Revista Argentina de Microbiologia

Volumn 37, Issue 1, 2005, Pages 34-45

  Vay, C A ^a   Almuzara, M N ^a   Rodriguez C H ^a   Pugliese, M L ^a   Lorenzo Barba, F ^a   Mattera, J C ^a   Famiglietti, A M R ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Antibacterial susceptibility; Gram negative nonfermentative bacilli

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULBACTAM; SULPERAZON;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CHRYSEOBACTERIUM; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OCHROBACTRUM ANTHROPI; PSEUDOMONAS STUTZERI; SHEWANELLA PUTREFACIENS; SPHINGOBACTERIUM MULTIVORUM; SPHINGOMONAS PAUCIMOBILIS; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 21244442698     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Akova M, Bonfiglio G, Livermore (1991) Susceptibility to β-lactam antibiotics of mutan strains of Xanthomonas maltophilia with high and lower-level constitutively-expressed class I β-lactamases. J. Antimicrob. Chemother. 25:199-208.
2. Appelbaum P, Spangler S, Sollenberger L (1986) Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, aminofloxacin, pefloxacin and cefpirome. J. Antimicrob. Chemother. 18: 675-679.
3. Appelbaum P, Tamin J, Stavitz R, Aber C, Pankuch A (1982) Sensitivity of 341 non-fermentative gram-negative bacteria to seven β-lactam antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 1: 159-165.
4. Baxter I, Lambert P (1994) Isolation and parcial purification of a carbapenem-hydrolisis metallo β-lactamase from Pseudomonas cepacia. FEMS Microbiol Lett. 122: 251-256.
5. Bellais S, Aubert D, Naas T, Nordmann P (2000) Molecular and biochemical heterogeneity of class B carbapenemhydrolyzing β-lactamase in Chryseobacterium meningosepticum. Antimicrob. Agents Chemother. 44: 1878-1886.
6. Bellais S, Naas T, Nordmann P (2002) Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing β-lactamase from Chryseobacterium gleum. Antimicrob. Agents Chemother. 46: 2791-2796.
7. Bellais S, Naas T, Nordmann P (2002) Molecular and biochemical characterization of Ambler class A extended-spectrum b-lactamase CGA-1 from Chryseobacterium gleum. Antimicrob. Agents Chemother. 46: 966-970.
8. Bellais S, Poirel L, Leotard S, Naas T, Nordmann P (2000) Genetic diversity of carbapenem-hydrolyzing metallo-β-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob. Agents Chemother. 44: 3028-3034.
9. Bellais S, Poirel L, Naas T, Girlich D, Nordman P (2000) Genetic-biochemical analysis and distribution of Ambler class A β-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob. Agents Chemother. 44: 1-9.
10. Biedenbach D, Croco M, Barrett T, Jones R (1999) Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolated including evaluation of disk diffusion and E test methods. Eur. J. Clin. Microbiol. Infect. Dis. 18: 428-431.
11. Brink A, van Straten A, Rensburg A (1995) Shewanella (Pseudomonas) putrefaciens bacteremia. Clin. Infect. Dis. 20: 1327-1332.
12. Cieslak T, Robb M, Drabick C, Fisher G (1992) Catheter-associated sepsis caused by Ocrhobactrum anthropi: report of a case and review of related non-fermentative bacteria. Clin. Infect. Dis. 14: 902-907.
13. Docqiuer J, Riccio M, Mugnaioli C, Luzzaro F, Endimiani A, Toniolo A, et al. (2003) IMP-12, a new plamid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate. Antimicrob. Agents Chemother. 47: 1522-1528.
14. Edwards J (1995) Meropenem: a microbiological overview J. Antimicrob. Chemother. 36 (S): 1-17.
15. Elting S Bodey G (1990) Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 69: 296-306.
16. Ezzedine H, Mourad M, van Ossel (1994) An outbreak of Ocrhobactrum anthropi bacteremia in five organ transplant patients. J. Hosp. Infect. 27: 35-42.
17. Fass R, Barnishan J (1980) In vitro susceptibilities of non-fermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev. Infect. Dis. 2: 841-851.
18. Fass R, Barnishan J, Solomon M, Ayers L (1996) In vitro activities of quinolonas, b-lactams, tobramycin, and trimethoprim-sulfamethoxazole against non-fermentative gram-negative bacilli. Antimicrob. Agents. Chemother. 40: 1412-1418.
19. Pass R, Prior R (1989) Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob. Agents Chemother. 33: 1268-1274.
20. Fraser S, Jorgensen J (1997) Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob. Agents Chemother. 41: 2738-2741.
21. Fujii T, Sato K, Inove M, Mitsuhashi S (1985) Purification and properties of a beta-lactamase from Alcaligenes xylosoxidans. J. Antimicrob. Chemother. 16: 297-298.
22. Fujii T, Sato K, Yokota E, Maefima T, Inove M, Mitsuhashi S (1987) Properties of a broad spectrum beta-lactamase isolated from Flavobacterium meningosepticum GN 14059. J. Antibiotics 41: 81-85.
23. Gilardi GL (1972) Infrequently encountered Pseudomonas species causing infection in humans. Ann. Intern. Med. 77: 211-215.
24. Gilardi GL (1986) Cultural and biochemical aspects for identification of glucose-nonfermenting gram-negative rods. En: Gilardi GL (Ed), Non fermentative gram-negative rods. Laboratory identification and clinical aspects, Marcel Dekker, Inc, New York, p.17-84.
25. Glupezynski Y, Hansen W, Freney J, Yourassowsky E (1988) In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob. Agents Chemother. 32: 276-278.
26. Goldstein E, Citron D, Merriam C, Warren Y, Tyrrell K (2000) Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. Antimicrob. Agents Chemother. 44: 2525-2529.
27. Higgins C, Murtough S, Williamson E, Hiom S, Payne D, Russell A, et al. (2001) Resistance to antibiotics and biocides among non-fermenting gram-negative bacteria. Clin. Microbiol. Infect. 7: 308-315.
28. Holmes B, Snell J, Lapage P (1977) Strains of Achromobacter xylosoxidans from clinical material. J. Clin. Pathol. 30: 595-601.
29. Holmes B, Snell J, Lapage P (1979) Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents. J. Clin. Pathol. 32: 73-77.
30. Kim J, Cooper R, Wetty-Wolf K, Harrel L, Zwadyk P, Klotman M (1989) Pseudomonas putrefaciens bacteremia. Rev. Infect. Dis. 11: 97-104.
31. King A, Bethune L, Philips I (1996) The comparative in vitro activity of FK-037 (cefoselis), a new broad-spectrum cephalosporin. Clin. Microbiol. Infect. 1: 13-17.
32. Legrand C, Anaissie E (1992) Bacteremia due to Achromobacter xylosoxidans in patiens with cancer. Clin. Infect. Dis. 14: 479-484.
33. Lesco-Bornet M, Bergogne-Bérézin E (1997) Susceptibility of 100 strains of Stenotrophomonas maltophilia to three b-lactams and five beta-lactam-β-lactamase inhibitor combinations. J. Antimicrob. Chemother. 40: 717-720.
34. Levesque R, Roy PH, Letarte R, Pedière JC (1982) A plamid-mediated cephalosporinase from Acrhomobacter species. J. Infect. Dis. 145: 753-761.
35. Lewin C, Doherty C, Govan J (1993) In vitro activies of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob. Agents. Chemother. 37: 123-125.
36. Lombardi G, Luzzaro F, Docquier J, Riccio M, Perilli M, Coli A, et al. (2002) Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase. J. Clin. Microbiol. 40: 4051-4055.
37. Louie A, Baltch A, Ritz WJ, Smith R (1991) Comparative in vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sporfloxacina (CI-978, AT-4140, PD 131501) and reference antimicrobial agents. J. Antimicrob. Chemother. 27: 793-799.
38. Mammeri H, Bellais S, Nordmann P (2002) Chromosome-encoded β-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (Formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes. Antimicrob. Agents Chemother. 46: 3561-3567.
39. Mandell W, Garvey G, Neu H (1987) Achromobacter xylosoxidans bacteremia. Rev. Infect. Dis. 9: 1001-1005.
40. rd. ed. Approved Standard M7-A3 National Committee for Clinical Laboratory Standards, Villanova, Pa. EE UU.
41. rd ed. Approved Standards, Villanova, Pa. EE UU.
42. Pedersen M, Marso E, Pickett J (1970) Non fermentative bacili associated with man III. Pathogenicity and antibiotic susceptibility. Am. J. Clin. Pathol. 54: 178-192.
43. Raimondi A, Moosdeen F, Williams J (1986) Antibiotic resistence pattern of Flavobacterium meningosepticum. Eur. J. Clin. Microbiol. Infect. Dis. 5: 461-463.
44. Ramos J, Román A, Fernández-Roblas R, Cabello A, Soriano F (1996) Infection caused by Ochrobactrum anthropi. Clin. Microbiol. Infect. 1: 214-216.
45. Reina J, Bassa A, Llompart I, Portela D, Borrel N (1991) Infections with Pseudomonas paucimobilis: report of four cases and review. Rev. Infect. Dis. 13: 1072-1076.
46. Rolston K, Messer M (1990) The in-vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 40 antimicrobial agents. J. Antimicrob. Chemother. 26: 857-860.
47. Saino Y, Inoue M, Mitsuhashi S (1984) Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob. Agents Chemother. 25: 262-365.
48. Saino Y, Kobayashi F, Inoue M, Mitsuhashi S (1982) Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22: 564-570.
49. th ed. ASM Press, Washington DC, p. 749-779.
50. Senda K, Arakawa Y, Ichiyama S, Nakashima K, Ito H, Ohsuka S, et al. (1996) PCR detection of metallo-β-lactamase gene (bla IMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34: 2909-2913.
51. Spangler S, Visalli M, Jacobs M, Appelbaum P (1996) Susceptibilities of non-Pseudomonas aeruginosa gram-negative non-fermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfa-methoxazole, and imipenem. Antimicrob. Agents Chemother. 40: 772-775.
52. Statement 1996 CA-SFM (1996) Zone sizes and MIC break points for non-fastidious organisms. Clin. Microbiol. Infect. 2 (S): 46-49.
53. Valdezate S, Vindel A, Baquero F, Cantón R (1999) Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 18: 908-911.
54. Vartivarian S, Anaissie E, Bodey G, Sprigg H Rolston K (1994) A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38: 624-627.
55. Vila Estapé J, Valls Lolla ME, Pumarola Suñé T, Jimenez de Anta Losada MT (1987) Bacilos gram-negativos no fermentadores aislados en enfermos hospitalizados. Enferm. Infecc. Microbiol. Clin. 5: 88-92.
56. th ed, ASM Press, Washington, DC, p. 520-532.
57. von Graevenitz A, Grehn M (1977) Susceptibility studies on Flavobacterium IIb. FEMS Microbiol. Lett. 2: 289-292.
58. von Graevenitz A (1985) Ecology, clinical significance, and antimicrobial susceptibility of infrequently encountered glucose-non fermenting gram-negative rods. En: Gilardi GL(Ed), Non fermentative gram-negative rods. Laboratory identification and clinical aspects. Marcel Dekker, Inc., New York p.181-232.
59. Weiss K, Restieri C, De Carolis E, Laverdière M, Guay H (2000) Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 45: 363-365.